Background Conventional chemotherapy agent such as doxorubicin (DOX) is of limited clinical use because of its inherently low selectivity, which can lead to systemic toxicity in normal healthy tissue. Methods A pH stimuli-sensitive conjugate based on polyethylene glycol (PEG) with covalently attachment doxorubicin via hydrazone bond (PEG-hyd-DOX) was prepared for tumor targeting delivery system. While PEG-DOX conjugates via amid bond (PEG-ami-DOX) was synthesized as control. Results The synthetic conjugates were confirmed by proton nuclear magnetic resonance (NMR) spectroscopy, the release profile of DOX from PEG-hyd-DOX was acid-liable for the hydrazone linkage between DOX and PEG, led to different intracellular uptake route; intracellular accumulation of PEG-hyd-DOX was higher than PEG-ami-DOX due to its pH-triggered profile, and thereby more cytotoxicity against MCF-7, MDA-MB-231 (breast cancer models) and HepG2 (hepatocellular carcinoma model) cell lines. Following the in vitro results, we xenografted MDA-MB-231 cell onto SCID mice, PEG-hyd-DOX showed stronger antitumor efficacy than free DOX and was tumor-targeting. Conclusions Results from these in vivo experiments were consistent with our in vitro results; suggested this pH-triggered PEG-hyd-DOX conjugate could target DOX to tumor tissues and release free drugs by acidic tumor environment, which would be potent in antitumor drug delivery.
References
[1]
Lacroix L, Commo F, Soria JC (2008) Gene expression profiling of non-small-cell lung cancer. Expert Rev Mol Diagn 8: 167–178.
[2]
Cuong NV, Jiang JL, Li YL, Chen JR, Jwo SC, et al. (2011) Doxorubicin-Loaded PEG-PCL-PEG Micelle Using Xenograft Model of Nude Mice: Effect of Multiple Administration of Micelle on the Suppression of Human Breast Cancer. Cancers 3(1):61–78.
[3]
Hu FQ, Liu LN, Du YZ, Yuan H (2009) Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles. Biomaterials 30(36):6955–63.
[4]
Ko JY, Park K, Kim QS, Kim MS, Ham JK, et al. (2007) Tumoral acidic extra- cellular pH targeting of pH-responsive MPEG-poly (b-amino ester) block copolymer micelles for cancer therapy. J Control Release 123: 109e15.
[5]
Zhu S, Hong M, Tang G, Qian L, Lin J, et al. (2010) Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style. Biomaterials 31(6):1360–71.
[6]
Murakami T, Sawada H, Tamura G, Yudasaka M, Iijima S, et al. (2008) Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy. Nanomed 3: 453–463.
[7]
Liao D, Liu Z, Wrasidlo W, Chen T, Luo Y, et al. (2011) Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity. Nanomedicine 7(6):665–73.
[8]
Chen CH, Liu DZ, Fang HW, Liang HJ, Yang TS, et al. (2008) Evaluation of multi-target and single-target liposomal drugs for the treatment of gastric cancer. Biosci Biotechnol Biochem 72: 1586–1594.
[9]
Gettinger S (2008) Targeted therapy in advanced non-small-cell lung cancer. Semin Respir Crit Care Med 29: 291–301.
[10]
Kakinoki A, Kaneo Y, Ikeda Y, Tanaka T, Fujita K (2008) Synthesis of poly(vinyl alcohol)-doxorubicin conjugates containing cis-aconityl acid-cleavable bond and its isomer dependent doxorubicin release. Biol Pharm Bull 31(1):103–10.
[11]
Xiong XB, Ma Z, Lai R, Lavasanifar A (2010) The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin. Biomaterials 31(4):757–68.
[12]
Chen W, Meng F, Cheng R, Zhong Z (2010) pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles. J Control Release 142(1):40–6.
[13]
Kotsakis A, Georgoulias V (2010) Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer. Expert Opin Pharmacother 11(14):2363–2389.
[14]
Pao W, Chmielecki J (2010) Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer 10: 760–774.
[15]
Cheng C, Wei H, Zhu JL, Chang C, Cheng H, et al. (2008) Functionalized thermoresponsive micelles self-assembled from biotin-PEG-b-P(NIPAAm-co-HMAAm)-b-PMMA for tumor cell target. Bioconjug Chem 19: 1194–1201.
[16]
Denmeade SR, Nagy A, Gao J (1998) Enzymatic activation of a doxorubicin-peptide prodrug by prostate-specific antigen. Cancer Res 58: 2537–2540.
[17]
Huan M, Zhou S, Teng Z, Zhang B, Liu X, et al. (2009) Conjugation with a-linolenic acid improves cancer cell uptake and cytotoxicity of doxorubicin. Bioorg Med Chem Lett 19: 2579–2584.
[18]
Lee AL, Yong W, Cheng HY, Pervaiz S, Yang YY (2009) The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles. Biomaterials 30: 919–27.
[19]
Leroux J, Roux E, Garrec D, Hang IC, Drummond DC (2001) Nisopropylacrylamide copolymers for the preparation of pH-sensitive liposomes and polymeric micelles. J Control Release 72: 71–84.
[20]
Lin J, Lin S, Zhu J, Chen T, Cai C, et al. (2009) Drug releasing behaviour of hybrid micelles containing polypeptide triblock copolymer. Biomaterials 30: 108–17.
[21]
Kukowska-Latallo JF, Candido KA, Cao Z, Nigavekar SS, Majoros IJ, et al. (2005) Nanoparticle Targeting of Anticancer Drug Improves Therapeutic Response in Animal Model of Human Epithelial Cancer. Cancer Res 65: 5317–24.
[22]
Fox ME, Guillaudeu S, Fréchet JM, Jerger K, Macaraeg N, et al. (2009) Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates. Mol Pharm 6(5):1562–72.
[23]
Sethuraman VA, Na K, Bae YH (2006) pH-responsive sulfonamide/PEI system for tumor specific gene delivery: an in vitro study. Biomacromolecules 7: 64–70.
[24]
Ryu BY, Sohn JS, Hess M, Choi SK, Choi JK, et al. (2008) Synthesis and anti-cancer efficacy of rapid hydrolysed water-soluble paclitaxel prodrugs. J Biomater Sci Polym Ed 19: 311–324.
[25]
Blanco E, Bey EA, Dong Y, Weinberg BD, Sutton DM, et al. (2007) Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells. J Control Release 122: 365–374.
[26]
Tae-Hee Kim, Christopher WM, Wayne RG, Suzie H (2010) The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles. Biomaterials 31: 7386–7397.
